Novo Integrated Sciences, Inc. (NVOS)

Market Cap	731.01K
Revenue (ttm)	13.29M
Net Income (ttm)	-16.17M
Shares Out	19.73M
EPS (ttm)	-0.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,400
Open	0.0400
Previous Close	0.0370
Day's Range	0.0340 - 0.0400
52-Week Range	0.0270 - 1.4100
Beta	-0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 20, 2024

About Novo Integrated Sciences

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline test...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Robert Mattacchione
• Employees: 230
• Stock Exchange: OTCMKTS
• Ticker Symbol: NVOS

Financial Performance

In 2024, Novo Integrated Sciences's revenue was $13.29 million, an increase of 5.75% compared to the previous year's $12.57 million. Losses were -$16.17 million, 22.3% more than in 2023.